Skip to content

Ayurvedic Management Of Scabies In Pediatric Age Group

A Comparative Clinical Study To Evaluate The Effect Of Dineshavallyadi Taila External Application Over Benzyl Benzoate In Management Of Scabies (Pama) In Children. - Nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086894
Enrollment
60
Registered
2025-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B86- Scabies

Interventions

None listed

Sponsors

Dr Rohan Dumbre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children diagnosed with Scabies (Pama Kushta) with clinical symptoms. 2. Children between age group 6-16. 3. Children of either sex irrespective of caste, religion, socioeconomic status

Exclusion criteria

Exclusion criteria: 1. Children suffering from any other systemic disorder like tuberculosis, HIV, leprosy, diabetes along with scabies (Pama). 2. Scabies leading to complications such as eczematization, secondory streptococcal Infection, urticaria

Design outcomes

Primary

MeasureTime frame
Dineshavallyadi Taila has significant efficacy than benzyl benzoate in the management of Scabies.Timepoint: 4 Months

Secondary

MeasureTime frame
No Chance of ReoccurrenceTimepoint: 4 Months

Countries

India

Contacts

Public ContactDr G G Patil

Shri Jagadguru Gavisiddeshwara Ayurvedic medical College Post graduation studies and research center

gaviayu@gmail.com9060896550

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026